ScoutQuest5 Oct 2026
Fredun Pharmaceuticals539730Warrant news

1,82,400 Equity Shares Allotted on Conversion of 60,800 Warrants

Company allots 1,82,400 equity shares of face value Rs. 10/- each after 60,800 warrants were converted.

25%Upfront portion of the warrant issue price
Upfront portion of the warrant issue price: 25%.
Equity Shares Allotted
1,82,400 equity shares of face value Rs. 10/- each
Warrants Converted
60,800 warrants
Warrant Issue Price
Rs. 1,250/- each
Upfront Payment
Rs. 312.50/- (25%) paid upfront
Warrants Outstanding
2,667 warrants remain outstanding

Fresh shares issued on warrant conversion

What the company informed

Price and the bonus adjustment

Who received the shares

The covering letter names 10 investors, each shown with warrants held, shares allotted on conversion, warrants still outstanding and the position after the bonus issue. Some of the larger allotments:

Other points from the update

In simple terms

This is the second leg of a fund-raising route where investors first bought warrants, paid a part upfront, and now pay the rest to receive shares. Because fresh shares are being issued, the total number of equity shares of the company increases by 1,82,400, which changes the percentage holding of every existing shareholder in the enlarged capital.

More numbers
  • Equity shares allotted on conversion of warrants1,82,400
  • Warrants converted into equity shares60,800
  • Face value per equity shareRs. 10/-
  • Issue price per warrantRs. 1,250/-
  • Amount payable upfront per warrantRs. 312.50/-
  • Upfront portion of the warrant issue price25%
  • Total convertible warrants allotted on December 29, 202572,000
  • Warrants outstanding for conversion2,667
  • Equity shares after effect of 1:2 bonus issue1,82,400
  • Equity shares per outstanding warrant after adjustmentthree
  • Number of investors10 (Ten)
  • Bonus issue ratio1:2
Source: BSE · 5 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.